Benefits of Nobivac® NXT-level protection
Smaller dose
A low-volume 0.5-mL dose for a more gentle vaccine experience
No extraneous material
Nobivac® NXT-level protection in a preservative-free, adjuvant-free,
thimerosal-free formulation
Targeted and efficient
Delivers the desired viral sequence to dendritic cells for an enhanced, precise immune response
Safety and efficacy
without compromise
Self-amplification triggers a robust antibody and cellular immune response without the use of an adjuvant or live organisms
Nobivac® NXT Canine Flu H3N2
Discover the first and only canine influenza vaccine to use RNA particle technology in a non-adjuvanted, low-volume vaccine.
Nobivac® NXT FeLV
Discover the first and only non-adjuvanted feline leukemia virus (FeLV) vaccine to use RNA particle technology to generate an efficient, comprehensive immune response.
The next chapter
of Nobivac®